List of works - Johannes Thaler

Androgen receptor dampens tissue factor expression via NF-κB and EGR1.

scientific article published on 10 February 2018

Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models--two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers.

scientific article published on 21 July 2011

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas

scientific article

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.

scientific article published on 7 February 2018

Clinical significance of circulating microparticles for venous thromboembolism in cancer patients

scientific article published on 20 July 2011

Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery.

scientific article published in December 2015

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.

scientific article

Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day

scientific article published on 13 March 2015

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS)

scientific article published on 11 December 2014

Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.

scientific article

Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.

scientific article published on July 2012

Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants.

scientific article published on July 2016

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.

scientific article published on 10 January 2017

Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study

scientific article published on 04 April 2011

Procoagulant extracellular vesicles in amniotic fluid

scientific article

Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).

scientific article published on 24 August 2015

Thrombosis risk and survival in cancer patients with elevated C-reactive protein

scientific article published on 01 January 2011

Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity

scientific article published on 23 June 2019

Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings

scientific article published on 28 August 2014

Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study

scientific article published on 24 September 2012

Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials

scientific article published on 26 July 2012

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.

scientific article

List of works by Johannes Thaler

Androgen receptor dampens tissue factor expression via NF-κB and EGR1.

Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models--two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers.

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.

Clinical significance of circulating microparticles for venous thromboembolism in cancer patients

Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery.

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.

Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients-results from the Vienna Cancer And Thrombosis Study (CATS)

Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.

Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.

Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants.

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.

Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study

Procoagulant extracellular vesicles in amniotic fluid

Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).

Thrombosis risk and survival in cancer patients with elevated C-reactive protein

Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity

Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings

Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study

Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.